JPS59500986A - Monoclonal antibody mixture and use of said monoclonal antibody mixture for sensitive immunoassays - Google Patents

Monoclonal antibody mixture and use of said monoclonal antibody mixture for sensitive immunoassays

Info

Publication number
JPS59500986A
JPS59500986A JP50204483A JP50204483A JPS59500986A JP S59500986 A JPS59500986 A JP S59500986A JP 50204483 A JP50204483 A JP 50204483A JP 50204483 A JP50204483 A JP 50204483A JP S59500986 A JPS59500986 A JP S59500986A
Authority
JP
Japan
Prior art keywords
antibody
mixture
antibodies
antigen
self
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50204483A
Other languages
Japanese (ja)
Inventor
キヤンフイ−ルド・ロバ−ト・イ−
エ−リク・ポ−ル・エイチ
モイル・ウイリアム・ア−ル
Original Assignee
ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク filed Critical ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク
Priority claimed from PCT/US1983/000751 external-priority patent/WO1983004312A1/en
Publication of JPS59500986A publication Critical patent/JPS59500986A/en
Pending legal-status Critical Current

Links

Abstract

(57)【要約】本公報は電子出願前の出願データであるため要約のデータは記録されません。 (57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 モノクローナル抗体混合物及び高感度イムノアッセイのための前記モノクローナ ル抗体混合物の使用本文に記載の発明は、National In5titut es of dealth、 UnitedStates Departmen t of Health and Human 5eryices 、lcD助 成金を受けたHD−13496、HD−15454及びCA−26636なる研 究の過程ではさnたものである。[Detailed description of the invention] Monoclonal antibody mixture and said monoclonal for sensitive immunoassays Use of a mixture of antibodies es of dealth, United States Department t of Health and Human 5eryices, lcD assistant HD-13496, HD-15454 and CA-26636, which received funding. This is something that was picked up during the research process.

発明の技術的背景 ハイブリドーマ技術の発達[G、 1(ohler及びC,m1lstein、  (1975)Nature 256 :495 :及びJ、 W、 Godi ng、 (198すImmunologicalMethods 39 : 2 85 ]に、c、p、唯1つの抗)JR’ N8位に結合する完投グロブリン試 薬が提供さGた。生化学的中段及び免役学的手段としてのこ扛らの試薬の使用は 晋及したが、ラジオイムノアッセイに於いては、血清抗体に比較して広原アフイ ニテイ(親オロ注)が低いため余ジ■効でないこと〃;多かった。(J、 W、  Goding。Technical background of the invention Development of hybridoma technology [G, 1 (Ohler and C, mlstein, (1975) Nature 256:495: and J, W, Godi ng, (198 Immunological Methods 39: 2 85], c, p, the only anti) JR' Medicine was provided. The use of these reagents as biochemical intermediates and immunological tools is However, in radioimmunoassay, compared to serum antibodies, Hirohara Affi There were many cases where it was not effective due to low nitei (parental note). (J, W, Goding.

(198すImmuno’logical Methods 39 : 285 3゜より敵背な〕・イブリドーマ洒択手順を綱いると一般的VCvまモノクロー ナル抗体のアフイニテイが同上した。更にモノクローナル抗体の産生によって研 死者は、俸漱兎佼応答全個々の純安紫に分析することかでさる工うi/l1mな った。[l’lJ、 A、 5taines及びA、 N1. Lew (19 80)、 Immunology 40 : 287 〕oこの結果4’に的に は、個々の抗体の磯罷に関して、荷に抗血清が個々の抗体を足し合せたものと、 ま異なる付性を有し得るCIT i目在に関してよす親指的な理解が傅ら扛るで あろフ。(198 Immuno’logical Methods 39: 285 3゜more hostile]・If you follow the Ibridoma selection procedure, it will be a general VCv monochrome The affinity of the null antibody was the same as above. Furthermore, by producing monoclonal antibodies, The dead can be analyzed by analyzing all the individual responses to I/l1m. It was. [l'lJ, A, 5taines and A, N1. Lew (19 80), Immunology 40: 287] o As a result, 4' Regarding the individual antibodies, the antiserum is the sum of the individual antibodies, I have a good understanding of the CIT index, which can have different attributes. Alof.

ヒト帳毛性ゴナドトロピン(hcG)の免役化学例えほこの分子の遣々のエピト ープの相対的配回及びホルモン−レセプター相互作用に於ける叔榎褪のモノクロ ーナル抗体の効果に関する体系的研究の過程で、成る孤のモノクローナル抗体の 屁仕切の見掛けのアフイニテイが1面々の抗体のアフイニテイに比!lツして同 上することが細見さt″した。Immunochemistry of human ciliary gonadotropin (hcG). A monochrome view of the relative distribution of hormone-receptor groups and changes in hormone-receptor interactions. In the course of systematic research on the effects of monoclonal antibodies, The apparent affinity of the fart partition is compared to the affinity of antibodies on one side! Same as before Hosomi was worried about going up.

発明の要約 抗原の異なる抗原部位に結付すること〃Sでさ適当な朱注丁で前記の結合を果し 借る少くとも2うMX#Iのモノクローナル抗%の合々を有効なアッセイ血で言 ゼするモノクローナル抗体屁片物は 抗原に対するアッセイの側矩j系度の同上 にゼ用でめる。Summary of the invention Binding to different antigenic sites of antigens At least two monoclonal anti-monoclonal antibodies of MX#I should be used in a valid assay blood test. The monoclonal antibody fragments that are produced are the same as those of the side effects of the assay against the antigen. It's for sale.

前記の即さ混合1グは時に、多欲エヒトープ=mする抗原、ν1jえは抗原の種 々の抗原部位/)3仇原内の榎々のアミノば配列から成るヒト絨毛性ゴナドトロ ピン、卵施刺原ホルモン、甲状腺刺激ホルモン又は天坏形成ホルモンの如きポリ ペプチドに対するアツセイに有用である。臨床的に重要な抗原アッセイに前記の 如き混合物を使用すると、個々のモノクローナル抗体を用いて得られる測定感度 に比較して旨い測定感度が侍らnるつ図面の簡単な説明 第1図:二抗体液相アツセイによるヒト絨毛性ゴナドトロビンのラジオイムノア ツセイ。非標識抑制因子が存在しないとさ結合した標識hCGの孟1工、抗体又 は抗体混片吻の谷々でほぼ1a]じでめった。この0111足は、抗体浴孜又、 ・ま混合物の各々のフ」適当な希釈によって行なわnた。第二抗体はウプギ抗− マウスI′gGでめった。抗体又7ま混♂物の各々についてED6o プラス/ マイナス憬早囲走を昇出した。BIOIとB102とのイ昆合窃のED、。は2 .44±0.74X10 M、仇1本B101では2,88士0.74 X l  0 1VI、抗体B102では1.058±Q、995XBIOI、Cは抗体 B]02の揚曾のhCGに対する禎きの5catchard 分析oMiの勾g +2(fつて半[fii f i d )は、A:5.4X l O’ ; B  : 5. l X 10’ : C: 1.9 X 1 t)”でりる。The above-mentioned rapid mixture 1g is sometimes expressed as a gluteal antigen, ν1j is the species of the antigen. Human chorionic gonadotrophs consisting of the amino acid sequences of each antigenic site /) 3 different antigenic sites Polymers such as pins, egg stimulatory hormones, thyroid stimulating hormones or thyroid-forming hormones Useful for assays against peptides. As described above for clinically important antigen assays Using mixtures such as A simple explanation of the Samurai drawing with better measurement sensitivity compared to Figure 1: Radioimmunoas of human chorionic gonadothrobin by two-antibody liquid phase assay. Tusei. In the absence of unlabeled inhibitory factors, labeled hCG bound to Meng 1, antibody or The antibody was killed at approximately 1a] in the valley of the proboscis. This 0111 foot is antibody bath Keimata, - Each mixture was prepared by appropriate dilution. The second antibody is Upugi anti- It happened rarely with mouse I'gG. ED6o plus/for each antibody or mixture Minus 昬 Waseda Soso started. The ED of the interception between BIOI and B102. is 2 .. 44±0.74X10M, one enemy B101 is 2,88 0.74Xl 0 1VI, 1.058±Q for antibody B102, 995XBIOI, C is antibody B] 5 catchard analysis oMi gradient for 02's hCG +2 (f and half [fii f i d) is A: 5.4X l O’; B : 5. l X 10': C: 1.9 X 1 t)".

第3A図: 二抗体液相アッセイによるhCGのラジオイムノアッセイ。第1凶 の礪せと同じ午ノ幀笛用いた。尻座AlO2のED、oは8.52±2.94  X 10 rVi、抗体B101では2.88±0.74 X 10 M、抗体 B101とAlO2との混合物では4.66±1.99X10 Mである。Figure 3A: Radioimmunoassay of hCG by two-antibody liquid phase assay. First evil It used the same gonohorobue as the one used in the song. ED, o of Shiriza AlO2 is 8.52±2.94 X 10 rVi, 2.88 ± 0.74 X 10 M for antibody B101, antibody For the mixture of B101 and AlO2, it is 4.66±1.99X10M.

第3B図: 抗体B101.B103.混合物B101+B103’z犬々田い た二抗体fL相アッセイによるhCGのラジオイムノアッセイ。第1図の場さと 同じ手順を用いた。Figure 3B: Antibody B101. B103. Mixture B101+B103’z Inunudai Radioimmunoassay of hCG by two-antibody fL phase assay. The place in Figure 1 The same procedure was used.

m: 固イ目アッセイにょるhCGのラジオイムノアッセイ。m: Radioimmunoassay of hCG using solid eye assay.

A:抗体B101及びB102及び混合物43101+13102゜B:抗体B 102及びB103及び混合物B102+B103゜g5図: パパイン消化B 102i用いた二抗体液相アッセイによるhCGのラジオイムノアッセイ。第1 図の’68と同じ手順を用いたが、但し、抗体−抗原懐曾体を沈殿させるための 第二抗体としてヤギ抗−マウスF(ab’J2 k使用した。第二抗体をこのよ うに変えても混合物のアフイニテイ瑠刀口に影響はなかった(結果図示せずう。A: Antibodies B101 and B102 and mixture 43101+13102°B: Antibody B 102 and B103 and mixture B102+B103゜g5 Figure: Papain digestion B Radioimmunoassay of hCG by two-antibody liquid phase assay using 102i. 1st The same procedure as in Figure '68 was used, except that for precipitating antibody-antigen receptors, Goat anti-mouse F (ab'J2k) was used as the second antibody. There was no effect on the affinity of the mixture even after changing it to sea urchin (results not shown).

ギ6図: B 101−F(ab’)2’<用いた二抗体液相アッセイによるh CGのラジオイムノアッセイ。第5図の場合と同じ手1貝ホルモン)とに対する A:B101とB102との混合物とB:ヒ)1&毛性ゴナドトロピンの種々の エピトープに対応するモノクローナル抗体を混δTると、抗原結合アッセイの測 定感度の同上が得らnることが覗祭さnた。抗体の組廿ぞの選択次第でtま、混 合物のアフイニテイを、別々にアッセイさ往たモノクローナル抗体のアフイニテ イの10倍にもすることができる。Figure 6: B 101-F(ab')2'<h by two-antibody liquid phase assay using Radioimmunoassay of CG. The same hand and shell hormones as in Figure 5) A: A mixture of B101 and B102 and B: Various types of 1&hairy gonadotropin. When mixed with a monoclonal antibody corresponding to the epitope, the measurement of antigen binding assay is It is evident that the same as above for constant sensitivity can be obtained. Depending on the choice of antibody group, there may be some confusion. Affinity of monoclonal antibodies assayed separately It can be made 10 times as large as A.

このように積別したアフイニテイは、固相アッセイ及び液相二抗体ラジオイムノ アッセイのいすnに於いても検出さfL侍る。Affinity segregated in this way can be used in solid-phase assays and liquid-phase two-antibody radioimmune assays. It can also be detected in the assay chair.

アフイニテイ壇刀口のメカニズムは多成分複合体の形成に依存する。同時に結合 することかでさない2棟類の抗体を混合してもアフイニテイ同上は生じないが、 適当な条件下で同時に結合し侍る抗体の組合せを用いると抗i、’KM台アッセ イの測定感度が向上する。混合に工ってアフイニテイ同上を生じた抗体の組合せ のうわの一力の抗体ンその抗体のF(aJ斯片に代えると向上がもは堂瑛出不K eになる。このことは、1同上がアロステリックな効果によるものでないりしい ことを示凌1−る。F(ab’)zffr片は別の抗体と混合ざnると成る種変 の向上を示すが、完全形(1ntact )の抗体と同程度の効果は示ざない。The affinity mechanism relies on the formation of multicomponent complexes. combine at the same time Even if two types of antibodies are mixed, affinity does not occur, but Using a combination of antibodies that bind together under appropriate conditions allows for anti-I, KM assays. The measurement sensitivity of B is improved. Combinations of antibodies created by mixing to create affinity If you replace it with the F (aJ fragment) of that antibody, it will no longer be improved. It becomes e. This does not seem to be due to an allosteric effect. I will show you that. The F(ab')zffr fragment forms a specie when mixed with another antibody. However, it does not show the same effect as the complete (1 ntact) antibody.

こnらの細見及び観察に基いて本発明は、抗原の高感度アッセイに有用、tモノ クローナル抗体の混合物を提供する。本発明の欠測に有用な抗体は更に、変性を 生じさせない標準条件下及び後述する叩き別の揚盆には抗原に結合し得る抗体が 結合できないような条件下の双方に於いて抗原に結合し得ることt待機とする。Based on these detailed examinations and observations, the present invention has developed a t-monoprotein that is useful for highly sensitive assays of antigens. A mixture of clonal antibodies is provided. Antibodies useful for the detection of defects of the present invention may also be denatured. Antibodies that can bind to antigens are prepared under standard conditions that do not cause antigen-binding and in a separate frying tray described below. It is assumed that the antigen can be bound under both conditions under which binding is not possible.

本文に紀・戊の弁明tgv則として、2種類以上のモノクローナル抗体を言み侍 る。谷々が抗原の別々の抗原部位に箱汗し侍る抗体を3橿頑又1ま4梶p又1・ まぞn以上含有する混合?Iは、多数のサブユニットをMするポリペプチドの如 き高分子のアッセイに荷に有用であろう。しかし乍ら以故の記載で、・ま、本発 明の実ν1jとして前記の如@抗体勿2柚・唄言Mする混合物について祝明する 。The main text states that two or more types of monoclonal antibodies are used as the TGV rule of Ki and Bo. Ru. The antibodies that are attached to the different antigenic sites of the antigen are 3, 3, 4, 1, 1, 2 and 3 A mixture containing more than n? I is a polypeptide with multiple subunits. It would be useful for loading into assays for large molecules. However, with the following description,... As the fruit of light ν1j, I congratulate you on the mixture mentioned above. .

ゴ囚当なモノクローナル抗体の7昆曾吻を1更用−[るアッセイによって利【々 のタイプの抗原の恢出が0J′罷でめったが・本発明は・イ徂々の尻原部征がボ リベフ゛チド(ハ)の個々の真なるアミノ鈑悶己夕1]から成るようなポリペプ チド抗原の咲出に時に適しているっこの梱の抗原のレリとして、ヒト絨毛1生ゴ ナドトロピン(hCG)。Seven antibodies of a monoclonal antibody were used in one assay. Although the discovery of this type of antigen was very difficult due to 0J', the present invention A polypep consisting of individual true amino acids of libertide (c) Human chorion 1 is used as a source of this antigen, which is sometimes suitable for the emergence of typhoid antigens. Nadotropin (hCG).

卯施府j倣ホルモン(FSd、)、甲状腺網]はホルモン(TSI(、)及び黄 体形成ホルモン(LH)のダロきホルモンに関連するd己グ1椀shる。Hormone (TSI (,) and yellow Body formation hormone (LH), which is related to the drowsiness hormone, is 1 bowl shul.

M効なアッセイτ行/ようには、アッセイ混合物中のモノクローナル抗体の各々 が 抗原への有意な結合を生じるに十分な童、即ち、抗体に同時に粘合されるべ き抗原の約10%τ上回る量で存在していなげればならない。好ましくは、結合 さnる抗原の麓がより多く、例えば約20乃至約80%又はそn以上の範囲の菫 でなσnばならない。M effective assay τ rows/so that each of the monoclonal antibodies in the assay mixture should be simultaneously attached to enough antibodies, i.e., antibodies, to cause significant binding to the antigen. It should be present in an amount about 10% τ greater than that of the antigen. Preferably, the bond The base of the antigen is higher, for example in the range of about 20 to about 80% or more. Dena σn must be.

FiiJ記のy口き孟の結汗抗原を得るために、ま、抗原に対する抗体のアフイ ニテイに基いて谷抗体の正味前を広い範囲で変更し傅るっ即ち、高いアフイニテ イをMする抗体の必賛重は低いアフイニテイを有する抗体の必安童ニジも少ない 。In order to obtain the sweat antigen of FiiJ, we first need to develop an antibody against the antigen. Based on the affinity, the net front of the valley antibody can be changed over a wide range, i.e., high affinity. Antibodies that have low affinity have low affinity, and there are also few antibodies that have low affinity. .

谷モノクローナル抗体間の相対的な童もまた広い郭抽に亘って変更し得る。2種 類の抗体の混合物の場合、この虚、工約106:l乃至1:10’の範囲で変更 し侍る。し〃・シ乍ら該当するモノクローナル抗体の特注決定の有力な要因と考 えろ扛る結合定数に基くと、前記範囲は好ましくは釣102:l乃至1:10” でりろう。一般に、別の抗体の童に対する谷抗体の好葦しい量は、抗原に対する 抗体の結合定数の比と冥買釣に同じでろろう。従って、モノクローナル抗体A及 びBの結合idが夫々10 及び10 の場合、AとBとの相対量は約10 / 10 =10でめる。即ち8100分子当りA1分子である。The relative size between monoclonal antibodies can also vary over a wide range of timescales. 2 types In the case of a mixture of antibodies of the same type, this value may vary from 106:l to 1:10'. Attend. This is considered to be a strong factor in the decision to custom order the monoclonal antibody. Based on the binding constant, the range is preferably from 102:1 to 1:10" Deriro. In general, the preferred amount of antibody against another antibody is It is probably the same as the ratio of binding constants of antibodies. Therefore, monoclonal antibodies A and When the bond IDs of A and B are 10 and 10, respectively, the relative amount of A and B is approximately 10/ 10 = 10. That is, 1 molecule of A per 8100 molecules.

ヒト繊毛性ゴナドトロピンのαサブユニット及びβププユニットのダロさサグユ ニットを言ひポリペプチド抗原の揚廿、抗体の各々が異なるサブユニットの抗原 部位VCC精子る工うなモノクローナル抗体の混合物は、該混合物を用いるアッ セイの測定4感度τ同上さぜ侍るでりろう。こ■、ま恐らく、抗体が適当な条件 Fで工9谷易に抗原に同時に納会し得るからでろりう。Detailed description of α subunit and β unit of human ciliary gonadotropin When a polypeptide antigen is raised, each antibody has a different subunit of the antigen. A mixture of monoclonal antibodies can be used to test the VCC site using the mixture. Sei's measurement 4 sensitivity τ Same as above. This is probably due to the appropriate conditions for the antibody. This is because in F, it is possible to use antigens at the same time.

、昆汗物は、前々の形状でアッセイに1炉用さn借る。便って、固体マトリクス に板層ざ′nた面体形で・1更用ざnてもよく、又は、適当な後備溶液に溶屏し た“漱不形で1更用さ扛てもよい。The kelp is used in the assay in its previous form. Stool is a solid matrix It can be used in the form of a face piece with a rough plate, or it can be melted in a suitable back-up solution. It is also possible to use one change in the form of a ``sufu form''.

混合物、・ま、該当するサンプル中の抗原の任在を足性的又、ま定量的に測定す るために、ラジオイムノアッセイの如キ従来のイムノアッセイで1更用さn侍る 。このような方法に於いてJま、混合物と抗原との+−s4で検出可能を俵合体 が形成され借る適当な乗件■でサンプルを混合物と接脂させる。1つの特定用途 としては、妊娠テストのためのヒト欣毛注ゴナドトロピンの咲出〃S享げら6る 。The presence of antigens in a mixture or sample can be determined quantitatively or quantitatively. For this purpose, conventional immunoassays such as radioimmunoassays can be used . In such a method, the mixture and the antigen can be detected by +-s4. Grease the sample with the mixture in a suitable manner to form a mixture. one specific use As for the development of human gonadotropins for pregnancy tests, .

不開明の−i!屏を助けるために一遅の央躾粕米を以Fに示す。Fukaimei-i! In order to help Byo, Ichisei's rice grains are shown below.

勿喘こnりの天砿は不発明の羊なる代表?+Jであり、本発明の範d全制限する と解釈ざ扛て1まならない。本発明の範囲は、後出の′#許請求の範dによって 限定される。Is Tensui of course a naughty representative of the uninvented sheep? +J, which completely limits the scope of the present invention. I can't help but interpret it as such. The scope of the present invention is determined by the claims d below. Limited.

材料及び方法 モノクローナル抗体の産生 vvands及びZurawskiの方法(J、L vVands+ V、 R,ZurawskL (198すGastroent erolog)r 80 : 225] f用い、Ba1b/ cマウスに対し て完全フロインドアジュバント中のhCGサブユニットの腹膜組織内注射を月1 回ずつ数カ月行なって免疫を与えた。牌ル@摘出の3日前に追加抗原を静注した 。Materials and methods Production of monoclonal antibodies: method of vvands and Zurawski (J, L vVands+ V, R, ZurawskL (198 Gastroent erolog)r 80 : 225] f for Ba1b/c mice intraperitoneal injection of hCG subunits in complete Freund's adjuvant once a month. Immunization was given several times over several months. The tile was given an intravenous booster antigen 3 days before removal. .

(生4貴塩水11:+50μ))。(Raw 4 noble salt water 11: +50μ)).

4則施會P 3 t’J Sl/T−Aり4−1 ミエローマ削成と融合させ、 ハイプリドーマ細胞を公知の手順で単離した( J、 R,VVandg 、  V。4 rules P 3 t’J Sl/T-A 4-1 Combined with myeloma reduction, Hybridoma cells were isolated using known procedures (J, R, VVandg, V.

R,Zurawski + (1981) Gastroenterology  80 : 225 :A、 tVIarshak−Rothatein %、 (1979) J、 Immunol、 122 : 2491 〕。以後の幼 児で使用さnた抗体は、Ba1b/c3T3単層上での眠定布釈によって2回り ローニノグしたハイプリドーマ軸施糸刀ユら単康さ扛たものである。抗体全1つ の文字と3つの数字とVCよって’la杯する。文字Bは抗体がhCGのβサブ ユニットに特異的でろること?示し、父子人は抗体がαサグユニットに結合する ことを示す。R, Zurawski + (1981) Gastroenterology 80: 225: A, tVIarshak-Rothatein%, (1979) J. Immunol. 122: 2491. later childhood Antibodies used in children were purified twice by constant dispersion on Ba1b/c3T3 monolayers. The Hypuridoma axis threading sword and the like are simple and easy to use. All 1 antibody The letters, three numbers, and VC make 'la cup. The letter B indicates that the antibody is β-sub of hCG. Something specific to the unit? The antibody binds to the α-Sag unit in the father and son. Show that.

細カ民上清又は部分精製もしくは梢製さ扛た抗体又はその双方を使用した。−分 硝羨抗体を侍るためには、2.・l/ゴのワシ血清アルブミンを言Mする無血情 理地中でハイプリドーマ細胞を増殖させ、上YWを0.051Viの炭は水系ア ンモニウムに透析した。Cell supernatants or partially purified or purified antibodies or both were used. - minutes 2. In order to attend to the Glass Enemy Antibodies.・L/Go's bloodless feeling of saying M's serum albumin Hybridoma cells were grown in soil, and charcoal with 0.051 Vi of YW was added to water-based water. Dialyzed against ammonium.

偲#乾腺鏝、所望量の0.3 Mのリン酸力ルシヮムバソファ、囲7、5 CF 3で粉末を護元した。精製抗体を得るためには、(培地に’*1nるワシ皿悄ア ルブミンの菫に0.1 rt9 /−にする以夕tは〕同じプロトコルを用い、 アルブミン全DEAEAffi −Gel Blueカラム(Bio −Lad  Laboratories )で除去した。偲# Dry gland trowel, desired amount of 0.3M phosphoric acid power Lucimba Sofa, Box 7, 5 CF I protected the powder with 3. In order to obtain purified antibodies, To make violet of rubumin 0.1 rt9/-, use the same protocol, Albumin Total DEAE Affi-Gel Blue Column (Bio-Lad Laboratories).

二抗体ラジオイムノア7セ(: 501ito”’I−hCGと50μtの非標 識h CGと(双方共、1%のウマ血清と99%のリン鍍塩緩衝生理食塩水に人 扛る)をIL)Oμtの0.3 M リン酸カル7ウム(pH7,5)と混合し た。次に、(1%のウマ血清に希釈した)lOOμtの抗体ケ碩加し、管を37 ℃で1時間、次に5℃で18時間インキュベートし、10Atの5Q%正常、マ ウス血清(リン敗塩緩衝生理食項水中りと適当量のウサギ抗−マウスIgG又は ヤギ抗−マウスF (ab’〕!とkg刀口して複合体を沈駿させた。沈板が終 rすると(即)37℃で10分間及び室温で1時間で頑次錐fj)沈殿物を沈降 ざぜて計数し7ζ。Two antibodies Radioimmunoas 7Se (: 501ito”’I-hCG and 50 μt unlabeled CG and (both were tested in 1% horse serum and 99% phosphate-buffered saline) 0.3 M calcium phosphate (pH 7.5) of IL) Oμt. Ta. Next, add 100μt of antibody (diluted in 1% horse serum) and remove the tube for 37 hours. Incubate for 1 hour at mouse serum (in phosphorus-salted buffered saline and an appropriate amount of rabbit anti-mouse IgG or The complex was precipitated with goat anti-mouse F (ab')!. Then (immediately) settle the precipitate stubbornly at 37°C for 10 minutes and at room temperature for 1 hour. Roughly count 7ζ.

面相ラジオイムノアッセイ: プラスチックマイクロタイターワエルを抗体でコ ートするために、Cookeマイクロタイタープレート(“U”ウエルリ甲で5 0μtの梢製抗体全5℃で18時間インキュベートし、蒸留水でワエルを3回洗 浄して余剰の井結オ抗体τ味云した。タンパクを結曾させる可能性のめるゲラス テック部位τ完全に距相する罠のに、グレートを10%のd曹 無γ−Gワマ皿r*(90%のリン酸;A緩衝生J1衆項水中りで処4し・余分 ケ蒸留水で味云した。狸々のtのbcGを言mするlギのウマJf!L r作中 の50μtの”’I−hCG紫奈刀口してhcG結i:iを尼櫨した。5℃で1 8時[i)のイン干ユベーショノ蚊、=m+の放射、Jとを呟云し、グレートを 蒸留水で抗争し、ワエルを計数し/ヒ。Facial radioimmunoassay: A plastic microtiter well is coated with an antibody. Prepare a Cooke microtiter plate (with a “U” well Incubate at 5°C for 18 hours and wash the wells 3 times with distilled water. After purifying the excess Izuo antibody, I tasted it. Geras has the potential to cause protein condensation. Although the tech part τ is a trap that completely ranges, the great is 10% d-sou. γ-G-free Wama dish r* (90% phosphoric acid; I tasted it with distilled water. L-gi horse Jf saying bcG of raccoon's t! Lr in progress 50μt of I-hCG was added to the hcG i:i at 5°C. At 8 o'clock [i), the insects were drying, and the radiation of =m+, murmuring J, and saying Great. Fight with distilled water and count the wael/hi.

サンドインチアッセイ゛: 少くともaotiW/mlのモノクローナル抗不全 8mする50μt’z96ウエルのマイクロタイタープレートに添加し、抗体紫 プラスチックの表囲に成層ぜしめた。Sand inch assay: Monoclonal anti-deficiency of at least aotiW/ml Antibody purple It was layered around the plastic surface.

37℃で4時間暢持故、浴販奮激云し、l・lり/ゴのウシ血清アルブミ7t− 6−Krる1 50 +nM(7℃%JaCte’JE (B S A−生理賞 鳴水月(プレートtf受側して、プラスチック次面の残りの非符異釣↓及看部位 で光債した。抗体fhCGで池邪する罠めに、このホルモン(50μtのJ3S A−生理″S:環水中に1μダ>を谷マイクロタイターウェルに2時間を安して 姫刀口した。この工う12未汗ドで、不4化ざnたhUGの丸んど、す5、グラ スチックに板層ざ扛た抗体に胎♂した。dSA−王理賞塩水浴欣千でプレートど 抗争して宗刺のhCGを麻云して。数訂症標識した仇体全冷加しくdsA−化4 !夾塩水浴液甲の50,000乃至ioo、oo。Because it lasted for 4 hours at 37°C, bath sales were booming, and 7 tons of bovine serum albumin. 6-Kr1 50+nM (7℃%JaCte'JE (BSS A-Physiology Award Narusui Moon (Plate TF receiving side, remaining non-standard position on the plastic side ↓ and see the part I took out a light bond. This hormone (50μt J3S A - Physiological S: Add 1 μDa to the microtiter well in the surrounding water for 2 hours. Himetou spoke. This work will be done in 12 minutes, with a round, 5, and 40mm round hUG. The antibody that was layered on the stick was injected into a female. dSA-Wang Li Prize salt water bathing plate I fought against him and took Sosaku's hCG. The body that was marked with a number of symptoms was completely cooled and turned into dsA-4 ! 50,000 to ioo, oo of salt water bath liquid A.

cpm月室温で2時rM」維持し、BSA−化4食項水田でプレートを抗争して 、結甘しなかったラベルを除去した。マイクロタイターウェル全ハサミで功分け て、谷ウェルに板層ざnた放射Ke全測定した。Maintain cpm at room temperature for 2 hours at room temperature, and then plate with BSA-treated 4-fed rice. , the unsweetened labels were removed. Micro titer well All scissors are used for success Then, the total radiation Ke of the plate layer was measured in the valley well.

別の材料及び方法: 既矧の方法[G、 M、 Edelrn幻η及びJ、 J 。Alternative materials and methods: Zheji's method [G, M, Edelrn illusion η and J, J .

+vlarchalonis、(1967〕 A4ethods in Imm unology and ImmunochemisLry。+vlarcharonis, (1967) A4methods in Imm unology and immunochemistry.

V’o1. I、405ページ、 Academic Press、 fiew  YorkJ k用いて抗体B102の消化を行なった。消化厘吻をドテシル疏 ばナトリウム(NaDod 5O4)ポリアクリルアミドゲル成気泳動(K、  vVeber及びrA、 0sborn、 (1969〕J、 8io1. C hem、 244 : 4406 ]にかげると、完全1(頻は要員的に全く残 存しないことが判明した。抗体t31.01のF (ab’ h tlT 片を 調装するため?こ(よ、ペプシン消化CG、 Gorini4、(1969)J 、 Immunol、 103 :1132 ] f用いたが、但し、ベグシン の重を抗体の前の2%*献%にした。木消化で残存L7j抗体を、p+(8,1 のProtein A−8epharose (PharmaciaFine  Chemicals )と共にインキュベートl、Protein A−8ep haroseと抗体との俵会体を遠心丁ゐことVCよって除去した。Ey寺が使 用した条件CP、L、Ey号、(1978)Immunochemistry  15 : 429.]と同様の条件を用いたが、但し、カラムクロマトグラフィ ーに代え又バッチプロセスを1更用した。還元剤を存在させ7IいでNa Da d S04ポリアクリルアミドゲル祇気体劾にかけると、分子量105,000 に唯1つの主要バンドが現nた。2801mでの元学漿朋とアミノ改屏析とVこ 工ってhCGの一度を測定した。V’o1. I, page 405, Academic Press, view Antibody B102 was digested using YorkJk. Digestive proboscis NaDod 5O4 polyacrylamide gel pneumophoresis (K, vVeber and rA, 0sborn, (1969) J, 8io1.C hem, 244:4406], it is completely 1 (frequently, there is no personnel left at all) It turned out that there was no such thing. Antibody t31.01 F (ab’ h tlT piece) To decorate? This (yo, pepsin digestion CG, Gorini4, (1969) J , Immunol, 103:1132] f was used, however, Vegcin The weight of the antibody was made 2%*% of the weight of the antibody. The remaining L7j antibody was digested with p+(8,1 Protein A-8 epharose (PharmaciaFine Chemicals), Protein A-8ep The aggregate of harose and antibody was removed by centrifugation or VC. Ey temple is enshrined Conditions used CP, L, Ey No. (1978) Immunochemistry 15: 429. ], except that column chromatography A batch process was also used instead. 7I in the presence of a reducing agent d When applied to S04 polyacrylamide gel, the molecular weight is 105,000. There was only one major band in existence. At 2801m, Gengakuseiho, Amino Kaiping Analysis and V-ko hCG was measured once.

クロラミン−T f:1ffi用し、Greenwood寺に工’)M(−載さ nた手11貞[F、 Greenwood 寺、(1963,l Bioche m、 J、 39 :114]に従ってhCGをヨウ素化した。Chloramine-Tf:1ffi, manufactured at Greenwood Temple 11 [F, Greenwood Temple, (1963, l Bioche m, J, 39:114] hCG was iodinated.

垣迷 ラジオイムノアッセイ: 放射イ也ヨウ累化hCGがモノクローナル抗体B l  01 、 B 102及びB101とB102との混合物の谷々に粕曾するこ とを抑制するhCGの目と力で比較した(第1図9゜混合物が使用ざ扛たときh CGは放射能ラベルの結片抑制に於いて20倍もの活性を示した。データの5c atchard分析にLflば、混合?1)よ、l3101単独に比べて前記同 様のアフイニテイ瑠力l]ヲ示し、B102単独に比べてはより以上の瑠刀0才 示した(第2図り。アフイニティが謂刀1したため、21重の抗体の1:1混曾 物を9倍に希釈し1面々の抗体と同じ童のトレーサー結付(11:達成すること 7り≦可吐でりった。表1に示す如く、こ扛らの結果は憾のて再現性が旨いっ本 文中にデータを示していない〃S、このような随同作用を示す2狸の抗体の能力 は、同じ丈ブユニットに結合する抗体の組合せに限ら、I’L +−jい、この ことは AlO2とB102との組合せ〃)この励同的相互作用ケ有することか ら明らかである。抗体の別の組甘せでに、同じ給米カ生じ117:)s ツfC 0即ち、dlolとAl 02 (第3A図9父はBioiとB103(第3B 図)との同では同様の動向作用、り5覗鯖されなかった。fence confusion Radioimmunoassay: Radioactive and cumulative hCG is used as monoclonal antibody B. 01, B102 and a mixture of B101 and B102. The effect of hCG on suppressing the CG was 20 times more active in inhibiting radiolabeled debris. 5c of data If Lfl is mixed in atchard analysis? 1) Compared to l3101 alone, the same The affinity of Ruki is shown, and compared to B102 alone, Ruto is more than 0 years old. (Second figure. Since the affinity was 1, a 1:1 mixture of 21 antibodies was used. Dilute the substance 9 times and bind the same child's tracer with one antibody (11: Achieve 7ri ≦ vomitable. As shown in Table 1, these results are unfortunately not very reproducible. No data shown in the text〃S, Ability of the two raccoon antibodies to exhibit such synergistic effects. is limited to combinations of antibodies that bind to the same long block unit. Does this mean that the combination of AlO2 and B102) has this exciting interaction? It is clear that With a different combination of antibodies, the same feed force was produced 117:)s fC 0, that is, dlol and Al 02 (Figure 3A 9 father is Bioi and B103 (3B In the same case as in Figure), a similar trend effect was not observed.

表 1 抗体B101とB102との混♂?Iに比恢した抗体B101及びB102のア フィニティのd針内分析* 5catchardプロツトを用いて測定〔G、  5catchard+ (1949)Anu、 N、 Y、 Acad、 Sc i、 51 : 660 ]**B101とB102との混合物のKeIHk  B 101のKe1!で除算した1匝。同上の程度?!−昇出丁ゐために、混合 物のアフィニティを、旨い刀のアフィニティを有する抗体のアフィニティと比較 している。Table 1 A mixture of antibodies B101 and B102? Antibodies B101 and B102 compared to I Finity d-needle analysis* Measured using 5 catchard plot [G, 5catchard+ (1949) Anu, N, Y, Acad, Sc i, 51: 660] **KeIHk of mixture of B101 and B102 Ke1 of B101! 1 sai divided by. Same as above? ! - Mixed for the sake of rising Comparing the affinity of a substance with that of an antibody that has the affinity of a delicious sword are doing.

gioiとAlO2とノr、を合物(父はBltJlとB103との混合’a) 、ま、2つの抗体の中間の仰制聞線を与えたつ面相ラジオイムノアッセイに於い ても+cT1gの栢米〃S明らかである(第4図9゜B101とB102との混 8?lY工単独の抗体のいずれ工りも高いhCGアフィニティをMすることが叔 祭さnた。但し、抗体8101と混合物との走は約4活に過ぎなかった。抗体B 102とB103との組合せではアフィニティ瑠加が生じなかった。A compound of gioi, AlO2, and norr (the father is a mixture of BltJl and B103) , well, in a phase radioimmunoassay that gave an intermediate line between the two antibodies. However, it is clear that the heather rice is +cT1g (Fig. 4, 9°) 8? It is unlikely that any antibody with lY alone would have high hCG affinity. It was celebrated. However, the migration between antibody 8101 and the mixture was only about 4 times. Antibody B The combination of 102 and B103 did not cause affinity Ruka.

サンドイッチアツセイ: アフィニティ変化のメカニズムヲ説明するテータτ侍 るために、hCGの種々の部位に結合する抗体の餌刀全サンドイッチアッセイを 用いて例」足した(表n)。Sandwich assay: Theta Samurai explaining the mechanism of affinity change In order to identify Examples were added (Table n).

非標識抗体と放射8154 iJ抗体とが同じ部位に精曾−fる場合、非標識抗 体lま、放射能ラベルの帖曾ケ迎市1]するでめろう。妃に、双方の抗体が異な る部位に渭せする揚台には、多重のラジオラベルがグラスチックVC結せさnる でりろう、標識B101と非標片虞BIOIとが1司時に抗原と給付すること、 工できない。この場合、プラスチックに結合さnた放射能ラベルは殆んど観察さ nなかったつ標識B102と非標識B102とt使用した場合にも同僚の結末ρ 1凛さnた。、抗体B102とB103とはいずnもdlolをプラスチックに m 汗せしのるのでBIOIの結合部位よりもぷい部位でhcGK鮎会した。更 に、標識B工02.ま、非標識B101に結付したhCGと結合した。対照的に 抗体A102fよ放射性13101の結合を阻止した。このことはAlO2とB 101と〃S同時にhcGに粘叶できないことtボアつ回、餞に、抗体B102 とB103とが同時に結計できないことも細見さnた。促って、島回的相互作用 のためには、興なる2つのhcG部位で抗体が同時に結合することが必要ではめ るが十分ではないと一=FJJ晴さnた。If the unlabeled antibody and the radioactive 8154 iJ antibody are injected into the same site, the unlabeled antibody The radioactivity label on the body is 1]. My wife has different antibodies on both sides. Multiple radio labels are tied to the glass VC on the lifting platform that is suspended in the area where it is placed. that the labeled B101 and the non-labeled BIOI are delivered as antigens at the same time; I can't do it. In this case, little radioactive label bound to the plastic is observed. Colleague's outcome ρ also when using n not labeled B102 and non-labeled B102 and t 1 Rinsa nta. , Antibodies B102 and B103 are both dlol and plastic. m Because I was sweating, I made hcGK sweetfish at a site that is wider than the binding site of BIOI. Change , sign B construction 02. However, it bound to hCG bound to unlabeled B101. in contrast Antibody A102f blocked the binding of radioactive 13101. This means that AlO2 and B 101 and 〃S cannot be applied to hcG at the same time, and once again, antibody B102 It was also noted that Hosomi and B103 could not be concluded at the same time. Encourage island-like interaction For this purpose, it is necessary for the antibody to bind simultaneously at the two hcG sites. However, FJJ said that it was not enough.

抗体断片の幼未: 動同注に対する抗体の信造の影響を研究するためにモノクロ ーナル抗体の町片會調製した。抗体8102tパパインで消化すると8101の アフイニテイを向上させる抗体B102の能力は泳云さnた(第5図り。しかし 乍ら、B102のパパイン消化によって、13102のhcGに対するアフイニ テイに侠出町罷な影響は生じな刀)つた。このことは、アフイニテイ向上のため に、抗体のFlc)鎖酸又は二画注が必−卆ろることを示す。二価のF (ab ’ )z を工結台アフィニティを成る程度同上させるが完全形の抗体e=と有 効でない(第6図及び表1゜表 1 モノクローナル抗体の組合−e−2使用したサンドイッチアッセイ数1ばは、グ ラスチックマイクロメイメープレートの表面に液層さt’LfchcG−非標識 抗体に特異的に粘合した抗体のcpm (3回の測定の平均値〕。非材典的に紹 甘しfcH射舵(即ち・ hCGし結合しないモノクローナル抗体の存在中でグ ラスチックに結合したものりは鼻スしなかった。The infancy of antibody fragments: monochrome to study the influence of antibody formation on dynamic injection A large number of antibodies were prepared. When digested with antibody 8102t papain, 8101 The ability of antibody B102 to improve affinity was demonstrated (Figure 5). However, by papain digestion of B102, 13102 was isolated to hcG. There was no chivalrous influence on Tei. This is to improve affinity. This shows that the Flc chain acid or double strand of the antibody is required. Bivalent F (ab ’) z to the extent that it has the same affinity as the one above, but the complete antibody e= Ineffective (Figure 6 and Table 1゜Table 1 Combination of monoclonal antibodies-e-2 The number of sandwich assays used was 1. A liquid layer is formed on the surface of the plastic micromechanical plate. cpm of antibody that specifically adhered to the antibody (average value of 3 measurements).Introduced non-typically. Amaishi fcH receptor (i.e., gluing in the presence of a monoclonal antibody that does not bind to hCG) The glue bonded to the plastic did not rub off.

* pく・001: 他の全てはゼロと有意な遅いはない。*pku・001: All others are zero and there is no significant slowness.

表 層 f 5catchard)゛ロノトヲ用いて2同定CG、 5catchard 。Surface layer f 5catchard)゛2 identification CG using Ronotowo, 5catchard .

(1949) Ann、N、 Y、 Acad、 Sci、 52 : 660  J**B101のKeqで除算したB 101 F (ab’)2とB102 との混合物の八eq。(1949) Ann, N, Y, Acad, Sci, 52: 660 J** B101 divided by Keq of B101 F (ab’)2 and B102 8 eq of a mixture with.

*** B l 01 F(ab’)2のKeqQ値は表IのBIOIノKeq の1直と竹怠な違いはない。*** KeqQ value of B l 01 F(ab')2 is BIOI Keq in Table I There is no difference between being on shift and being lazy.

考察 モノクローナル抗体の混合物は、個々の成分に比軟して重要な違いを待つ時性を 肩し侍る。ノ・イブリドーマ抗体の混合物のアフイ0ティρ3同上し侍ることは 明ら刀)にさnた。モノクローナル抗体の別の荷i)よ、1つより多いノ・イブ リドーマ抗体の使用によって筑に改良きれている。Hzbe r寺(E、 fh ber 4、(198すResolving antigenjc 5ites  and purifying proteins with monoclo nalantibodies”+ +VIonoclonal AnLibod ies in P2ndocrine Re5earch、 RavenPre ss ] rま2棟のモノクローナル抗体を用い各々の抗体を別々に用いたアッ セイニジも高度な符異注を臂するランオイムノメトリツクアツセイヲー発した。Consideration Mixtures of monoclonal antibodies are sensitive to important differences compared to their individual components. Attend on your shoulders. Affection of hybridoma antibody mixture (obviously, a sword). Another load of monoclonal antibodies i), more than one antibody Significant improvements have been made through the use of ridoma antibodies. Hzbe r temple (E, fh ber 4, (198 Resolving antigenjc 5ites and purifying proteins with monoclo nalantibodies”+ +VIonoclonal AnLibod ies in P2ndocrine Re5earch, RavenPre ss] An assay using two monoclonal antibodies and using each antibody separately. Seiniji also launched a series of immunometric tests that were highly controversial.

f(oward寺(J、 C,doward %、(1979)Immunol ogical Rev、 47 : 139 3はモノクローナル抗俸の#!i 合せが亦皿球浴屏に相末注を示し侍ゐことを証明した。モノクローナル抗体の利 点ののるもの、タリえば卑−決定基との反応能、よ屁廿によって大なわnるかも 却n、lいが、多くの利点はFIT開相求的抗皿清血清生に薔与するでめりつ。f (oward temple (J, C, downward%, (1979) Immunol logical Rev, 47: 139 3 is the # of monoclonal anti-salary! i He also showed the endnotes on the bathing screen, proving that he was a servant. Benefits of monoclonal antibodies The ability to react with the base determinant of the one on which the dot is attached may be greatly increased depending on the situation. However, there are many advantages to using FIT-opened anti-plate serum serum.

こaうの絶景lよlた、抗坏汁成のコノトロールとインビボ兎没応谷とにも関与 するでろろう。抗体の混合物、・ヱ(混甘ざrした抗俸久第で9個々の抗体とは 異なる荷注を廟−するので、別の5答が適片注抗体の混片”F/lを生じゐと考 えらnる。iHって、机面mのアフイニテイのR18の原因は、CE、 Kar ush、 (1978)Comprehensive Immunology5 + Immunoglobulins pp、 85+ Plenum tvl edical Book co、、 fJew York〕尚アフイニテイクロ ーン刀5刺激さ扛たCとにめるの6でなく、皿7W中に丁でに存在する別の抗体 のアフイニテイ會同上させ併る抗体rJ’産生さ/1.たことにりるのかも仰n ない。In addition to the spectacular view of the sea, it is also involved in the anti-seizure conotrol and the in-vivo rabbitfish valley. I would. A mixture of antibodies, Since different quantities are used, another 5 answers are considered to produce a mixed fragment of the antibody "F/l". I'll choose. iH, the cause of affinity R18 on desk m is CE, Kar ush, (1978) Comprehensive Immunology 5 + Immunoglobulins pp, 85 + Plenum tvl edical Book co, fJew York Another antibody present in the dish 7W, but not in the dish 5 stimulated with C and nimeru. Antibody rJ' produced by the same affinity association as above/1. I don't know if it's true. do not have.

叡侃類の抗体混汁物に関するテストを大流した。抗体B101と抗体AlO2と ?組合せた揚−片、予ブωの用量一応谷l」線が侍うt″L、た。即ら、ロジッ トプロットに工nは混什吻の迎制線〃;個個の抗体の迎制BB課のf間に存在し た。、t3101とAlO2と、まhCGに1司時に粕さすることVまでさない 。このホルモンVC回時にt5曾し侍る抗体13101とB103とτ甜片ぜた 揚台、混合物のロジットプロット1ま、低い抗yA傭緩ct工尚アフィニティ抗 体のプロットに従践し、高い仇涼譲度では低アフイニテイ抗体の薇に近似する。A large number of tests were carried out regarding the antibody mixture of Eikai. Antibody B101 and antibody AlO2 ? The combined lift piece, the amount of pre-bu ω, the valley l' line meets t'L, that is, the logic. In the top plot, n is the mixed control line; it exists between f of the BB section of the individual antibodies. Ta. , t3101, AlO2, and mahCG at the same time, I don't even bother V. . During the VC cycle of this hormone, T5 is present with antibodies 13101, B103, and τ Lifting table, logit plot of mixture 1, low resistance yA, low resistance CT engineering affinity resistance The plot follows that of a low-affinity antibody at high yields.

抗体giuiと13102とのα片切は、混合物、35個々の抗体のい丁n工り も尚(゛アフイニテイ全示したため我々の幼児の主要な成果である。表1[ボr 如く、この結果は再睨注がめす、就訂的VCも性悪でるる。α-sections of antibodies GIUI and 13102 were obtained using a mixture of 35 individual antibodies. Table 1 [Volume As expected, this result will make us pay close attention to the fact that even the VCs who are currently in the process of revising the program are being criticized.

動量作用のg fEb=碓超さnたのでメカニズムの解明が+%1 rdA K なる。抗体に代えてF(息b)研片會用ん゛ると、同上の程度、少減少しfco cv)こと、工、協同仕に関する2つの車装な層性を示す。The elucidation of the mechanism is +%1rdAK because the dynamic action g fEb = Usudasa n Become. If F(breath b) laboratory test is used instead of antibody, fco will decrease slightly to the same extent as above. cv) Shows the two layers of vehicle design related to work, engineering, and cooperation.

第一に、F’(ab、)工り大きい抗体断片が必賛でめる。第二に、1つの抗体 の結付がホルモンの配膳を変化させて第2抗体のアフイニテイヲ烏めるというo T能在は(アロステーリックなモデル)オえりt′Lない。別の考え力にエフ’ Lば、同上を生起するのは二1曲の抗体と抗原との分子間架偏でろるという祝明 も口■症でるるかも仰nない。(汐りえは、2つの抗体及び2つの抗原の分子力 )り成る碩状榎合体が形成さrしる揚せ。Schumaker 寺に工n−ばこ 扛は塵めて安定な咳合体であると予(1111ざn1いる[ V、 N。First, large F'(ab,) engineered antibody fragments are available. Second, one antibody It is believed that the binding of these molecules changes the distribution of hormones and impairs the affinity of the second antibody. T'nozai (allosteric model) is not ot'L. F’ to a different way of thinking L. It is a blessing that the above occurs due to the intermolecular bias between the antibody and the antigen in 21 songs. I'm not worried that I might get mouth disease. (Rie Shio is the molecular force of two antibodies and two antigens. ) is formed, forming a staghorn-like amalgamation. Schumaker temple n-bako I think that the cough is a stable combination of coughs (1111 and n1 [V, N.

Schumaker @、(1973) Immunochewistry 1 0 :521] )OF(abつ2に関する結呆刀詣らは、少くともこnが唯1 つのメカニズムでないことが示唆さ扛る。゛よた。俟合体甲のF(c)鎖酸の相 互作用は漱相ラジオイムノアッセイかうの全てのデータと一蚊しているが、面相 アッセイから刊町すると、仇坏、p5丁でにプラスチックに固定さnて2り同上 が依然として生じるのでFIc)相互作用が唯1つの安因でfエバよ(゛と考え ら7Lる。勿罐、2種のアッセイの4片でメカニズムが異なっでいるのかも矧汎 ない。破故に、抗体dlulとB”103とに関する結果、即ち、これらの抗体 ぴhccK同時に結付できるにも関らず動量的相互Y1し示さないと〜・C)粘 釆V工、イティオタイプー抗−イディオタイプ相互作用が厘妥な仮割愛釆丁らし く゛・ことを示唆する。(即ら、j31L)1とI31θ2と、ヱ、h c G  vc紹片した故に筏ざ扛た遊離fi’(a6 )アーム間のイディオタイプ− 仇〜イティオタイプ相互作用をMする771も’mn1tい、 し27h L  Ipらd I Q lトn l 03トr!コノL’)な関係を待たない。すし かし乍ら懺調丁べさ汀、BIOIとB103とが向上茫示ざ、T(゛という華英 イヱ1個々の抗体の成る橿の符頭(11PIJえばエピトープの空回「ジ配同又 lまイティオトーグの江負)が励1可と月用に於いて憾ので重要でめるというこ との預刀なV箱拠になることでΦろう。メカニズムの符江の光全な解明を行なう たのには史に実豪を夏ねる必要〃5ある。Schumaker @, (1973) Immunochewistry 1 0:521]) OF(abtsu2) This suggests that there is no single mechanism for this. Yota. F(c) chain acid phase of the combined shell Although the interaction is consistent with all the data from the phase radioimmunoassay, there are no significant differences. When the assay was completed, it was fixed to the plastic with a plate of 5 pieces and 2 pieces as above. Since this still occurs, we believe that the FIc) interaction is the only safe cause and that 7L. I wonder if the mechanisms are different between the four strips of the two types of assays. do not have. Therefore, the results regarding antibodies dlul and B''103, i.e., these antibodies Even though PhihccK can be bound at the same time, if the dynamic mutuality Y1 is not shown... C) Viscosity Kawa V-tech, itiotype-anti-idiotype interaction seems to be reasonable. It suggests that. (i.e. j31L) 1 and I31θ2 and ヱ, h c G Idiotype between the free fi' (a6) arms that was destroyed because of the vc introduction. 771 that causes itiotype interaction is also good, and 27h L Ip et al d I Q l to n l 03 r! Don't wait for a relationship like this. Sushi However, BIOI and B103 are showing signs of improvement. 1) The notehead of each antibody (for example, 11 PIJ is an epitope empty cycle, It's important to note that Itiotog's Eiji) is regrettable in the 1st month and the 1st month. By becoming a V-box base with a guarded sword, it will be Φ. Complete elucidation of the mechanism In order to do this, there is a need for a summer of experience in history.

抗体の虎オf/I、ii個々の抗体よす扁いアフィニティをMし侍ること・よ2 つの重要な意廐をざむ。g−に、モノクローナル抗体のアフイニテイを同上ざぜ る1娩会〃≦与えっ柱り0第二に・林知の糸に於いて一遅の抗体を混片し侍るこ とにより、ポリクローナル兄反皿rげ甲に生じる仮組な幼果の工9児全lよ4解 かoJ I目に5橿頑のモノクローナル抗体の2つ丁つの組8ぜの全てに関して ラン第1ムノアツセイ全実流し、相末的相互f用の程度(prevalence  )全測定し尺。入域1ま、二抗体ラジオイムノアッセイで測定さrたとき相末 1’Eを示す(混酋ざ7Lると抗原に対するアフイニティが1司く孟る)抗体の 耐Gせを示す。プラス符号は・表の上側の抗体〃5左偵の抗体と相乗在でのるこ とを示し。Antibody tiger f/I, ii M and serve the small affinity of individual antibodies 2 It conveys two important meanings. g-, the affinity of the monoclonal antibody is the same as above. 1 Birth party〃≦Giving Pillar 0Secondly, in the thread of Hayashi Chi, I will mix the late antibodies and attend. Due to this, there are 4 results for all 9 children with pseudo-assembled young fruits that occur in the polyclonal older brother. Concerning all of the two pairs of monoclonal antibodies in Run 1st munoassay all actual flow, successive mutual f for degree (prevalence) ) All measurements and length. The phase end was measured by two-antibody radioimmunoassay. 1'E (if mixed with 7L, the affinity for the antigen will be 1). Shows G resistance. The plus sign is the antibody on the upper side of the table, which is synergistic with the antibody on the left side of 5. Indicates.

マイナス符号は相末的相互1′[用び燕(゛ことt示す。The minus sign indicates a mutually exclusive 1' [and Swallow (゛).

辰によnげ、10個の町Weな組付せの9りで5つの紐付せ〃3相末註でるる。In the dragon, there are 5 strings in the 9th part of the 10 towns.

要隷に汀、こnらの抗体のうりのめるものは如何!よる栄往Fでも同時に抗原に 結付すること〃5でさないので、比4Jま更に高くIよる。こrLらの粗汁ぜt 除去すると、7つの組付せのううで5つの、!ll1片せが@末注で必る。Well, what do these antibodies do? At the same time, it becomes an antigen at the same time. Because it is not connected in 〃5, the ratio 4J is even higher than I. KoroL et al.'s crude soup When removed, 5 out of 7 assemblies! ll1 katase is required @endnote.

モノクローナル抗体のα片切の符真注の墳刀口m’ 7 図rよ、n1oiと4 31 @ 2と〕737. オ’fill、[i+d101&ひ抗体B I U  2の夫々〃1heG (−fig)とhLH(=oて随似した何項のホルモン ラとに関して示すロジット抑制曲線全示す。Figure r, n1oi and 4 31 @2 and] 737. O’fill, [i+d101 & antibody B IU For each of 2, 1 heG (-fig) and hLH (=o), which hormones are similar? The logit suppression curves shown for la and are shown in full.

妊、瀝及び癌の診萌には、こ扛もの2億のホルモンの識別が憾りて車装でめる。For diagnosis of pregnancy, death, and cancer, this device is equipped with the ability to identify 200 million hormones.

グラフAt工、BIOI(!:f31L12との混汁吻がhLHに対するより酌 170倍も頻カにhcGに頑6し侍ること’?を示゛fo!う7BはBIOI、 p;bLf(に対する。Cり約50倍頻刀にhCGに精会し侍ることを示す。グ ラフC7より102がhCGに刈してhL)fの約10・后の感度を有すること t示す。Graph At engineering, BIOI (!: Mixed juice proboscis with f31L12 is more considerate to hLH To serve hcG 170 times more often? Show fo! U7B is BIOI, p; bLf (to. From rough C7, 102 is cut to hCG and has a sensitivity of about 10. after hL) f. Show t.

従って、抗体の混合物lま1+MJ々の抗体ニジも、エタ符異釣でめる。Therefore, a mixture of antibodies 1+MJ can also be mixed with different antibodies.

混甘さnると抗原に対するアフイニテイが同上する工うなモノタローナル抗体の ′F−F註犬足を更に進めるたりに、更に研究を続けた。こγしらの研究によt は、この特性をMするモノクローナル抗体は、仇不混酋物と抗原との間に安定な 候曾俸を形成し得る舵力に基いて、前記の特性を待たない抗体力)ら識別さn侍 る。この鎮台体7よ、ゲル亀気累拗に於(゛てエキストラバンドとして机わnた 。The sweetness of the monotalonal antibody increases the affinity for the antigen as described above. 'F-F Note: As I progressed further, I continued my research. Through this research Monoclonal antibodies that have this property are stable between immiscible substances and antigens. Samurai are distinguished from those who do not have the above-mentioned characteristics on the basis of their rudder power, which can form a competitive advantage. Ru. This Chindai 7 is in a state of intense gelatinousness (and has been acting as an extra band). .

L911+釉には、1乃至5μ)のhCGと1乃至5μ7の抗体Yjb 8 m とを、3+ 4 + 5+ 6及び7%のポリアクリルアミドゲルを人7した長 さ111の信に人nだ。営に対しで、宮当94ミリアンペアの定電流を作用させ た。1更用力法は、P、 d、 0’Farrell。L911+glaze contains 1 to 5μ) of hCG and 1 to 5μ of antibody Yjb 8m and the length of 3 + 4 + 5 + 6 and 7% polyacrylamide gels I'm a believer in 111. A constant current of 94 mA is applied to the Ta. 1 addition force method is P, d, 0'Farrell.

(1975)J、 Biol、 Chem、 250 :4007−40211 clj’;いて自IJ仄的に起部さnた方法と≠買的に同じでりるが、但し、S O8+ま1更用しな刀λつた。分酊故、ゲルを適当な采料で采色した。(1975) J. Biol. Chem. 250:4007-40211 clj'; The method is essentially the same as the method used to create the original IJ, but with the exception that S O8+Ma1 updated sword λtsuta. Due to the intoxication, the gel was dyed with an appropriate dye.

モノクローナル抗体混合物と抗原との間の複合体の形成に丞〈エキストラバンド の出現は、過当な抗原のアッセイVにの工つなモノクローナル抗体を1挺用する と測定感度の同上が侍らnることを示夕丁ゐ。For the formation of a complex between the monoclonal antibody mixture and the antigen, The emergence of a single, sophisticated monoclonal antibody for the proper antigen assay V This shows that the measurement sensitivity is the same as above.

アフイニテイ1同上を生じる抗体の組甘ぞは、電気原動法以外にも、ゲルP増ク ロマトグラフィーでのエキストラ高分子型ピークによって酪酸さ′n−た。ニジ 詳細に1ま、過電の放射性ヨウ素化hcG(0,1乃至10.0μCi)をき/ Piするl乃至5μqのhCG:1乃至10μ7の抗体混合物と混合し、O,0 15MのHerpesバッファ、 pt47.4−0.9%i”Jact−I  Aす/mIB S A中で、ば径1 tx 、艮ざ24−の5ephacryl  S −400カラムでクロマトグラフ処4した。アフイニテイ同上を生じるB 101+B102+hCGの混合物はエキストラビークを生じたが、浴液中でア フイニテイ同上を生じな(・ことiJ”j) ン0”っていたBIOI十B 1 03+hCGのイ昆叶吻はエキストラビークを生じな刀)つた。従って、この手 順も、どの抗体の組合せが有効でりるか玄火定丁/:I7tりに1更用丁ゐこと 炉できる。In addition to the electrokinetic method, the combination of antibodies that produce affinity 1 as above can be determined using gel P increase method. Butyric acid was detected by the extra high molecular weight peak in the chromatography. Niji In detail, an overcharged radioiodinated hcG (0.1 to 10.0 μCi) was applied. 1 to 5 μq of hCG to Pi: mixed with 1 to 10 μ7 of antibody mixture, O,0 15M Herpes buffer, pt47.4-0.9%i”Jact-I A/mIB S In A, 5 ephacryl with a diameter of 1 tx and a width of 24- Chromatography was performed on an S-400 column. B causing affinity ditto The mixture of 101+B102+hCG produced an extra peak, but the mixture of BIOI 10B 1, which did not cause Finitei the same as above. 03+hCG's i-konba proboscis produces an extra beak. Therefore, this method In order, it is important to know which combination of antibodies is effective. I can make a furnace.

符に、アッセイの測定!感度7同上させるためりモノクローナル抗坏混汗吻の使 用に関して不元明?祝明してさたρS、不元明は、+j典注の同上を与えるため の混合物の1挺用をも也Sし、lた、佇後尭児ざnるかも却扛I工い別の1旧別 えは傭々の条件に対するインビボ処理力法のための混合物の1更用をも&゛ざす るこ8、補正の内容 (1)出願人の代表者を正確に記載した特許法第184条の5第1項の規定によ る書面を別紙の通り補充する。Measure the assay to the mark! Use of Tamari monoclonal anti-sweating proboscis that makes sensitivity 7 same as above. Not sure about the purpose? Congratulations, ρS, Fuyuan Ming, to give +j ditto of the annotation. It is also possible to use one bottle of the mixture of The present invention also aims at further application of the mixture for in vivo processing power methods for various conditions. Ruko 8, Contents of correction (1) Pursuant to the provisions of Article 184-5, Paragraph 1 of the Patent Act, which accurately describes the representative of the applicant. Supplement the documents as shown in the attached sheet.

■タイプ印書により浄書した請求の範囲第29ページの翻訳文を別紙の通り補充 する。(tt”)@−二事ψも・)(4)委任状・法人格証明書及び翻訳文を別 紙の通り補充する。■ Added the translated text on page 29 of the claims, which was typewritten and printed, as shown in the attached document. do. (tt”) @-Two things ψ too・) (4) Power of attorney/corporate personality certificate and translation separately Replenish as per paper.

国際調査報告 794”“!19−500!18Ei (jの]フ ヨ 」 第1頁の続き 0発 明 者 ニーリフ・ポール・エイチアメリカ合衆国ニュー・ヨーク100 25ニユー・ヨーク・ヘイヴン・アヴエニュー00 @発明者 モイル・ウィリアム・アールアメリカ合衆国ニュー・ジャーシイ08 854ピスキヤツタウエイ・リヴアー・ロード952International search report 794""! 19-500!18Ei (j's) Yo ” Continuation of page 1 0 shots by Neeliff Paul H New York 100, USA 25 New York Haven Avenue 00 @Inventor Moyle William Earl New Jersey, USA 08 854 Pisquitaway River Road 952

Claims (1)

【特許請求の範囲】 1. 丈ンプル甲の抗原τ快出丁々たのり尚感・支アツ七イV(有用なモノクロ ーナル抗体の混片吻でりV、抗原の異なる抗原部位lc、霞甘すせ少くとも2佃 :噛のモノクローナル抗体り谷々τ/d幼アッセイ81式ご言んで:i?9適当 な条汗ドで抗原と全てのモノクロ♂物。 2、 24iAリモノクローナル仇坏tざむ誼ボの氾ア@ l vごう己或の混 オ吻り 3、削、七仇原、)・ボ1ノ ペフ゛チ ト (: > 9 Ai+ :氾仇亦 +31i反・)iHlり記・丁すペプチドにざぽノしたアミノ敏活Cクリ゛でり る61イzくのl巳ノ4刊iに1−己械の7昆寸吻。 4、 月11.己ホリペフチド仇り式、ノぶヒトrR宅旺コ′ナトトロヒシ(2 りゐ=t4 ポL7Jfi−レジ:’rr’J 1 v(iif;4Qζ−6二 )7m 61勿、v5、 削60ポリベグナト仇原、0・卵+g #ljはホル モ/で・りる1;dぢくの軛、z6 1 vc5己−+tv、 ’D i B゛ ?/I 1b、j(jl (i己ホリペノ゛チド1JT、7jjL 、)i甲状 J lij 7ホルモンでりる1jrJ ;F−の屍dlvc記I戊の屁旨切コ ア、aIJ記ポリペプチド17LIJA2J(貢小ル成ホルモンCリクパぼ珂く の兆、え目1に記Ii民のイ屁♂1グ。 8、 角Og己M効アッセイ重が、削6己サンプル千に4在する616己抗原の 少くとも約10%ρS削記女定な仮台ネオ形成するたのに十分7よ各モノクロー ナル抗体の賞でりる請求の4QI51にう己舐の混合物。 9、別の抗体の菫【対する谷抗体の友〃・約10’:l乃至約1:106のiα l甜でめる請求の範囲1に6ピ載の混合物っio、前記磁が幻10”:l乃至f Jl:10”の範囲でりる請求の軛d9にd己載の7昆曾吻。 11、別の抗体の蛍に対する谷抗体の盾が 抗原に対する抗体の粕寸定畝の比と 実買−に同じでめる請求の範囲9に記載の混曾J0 12、 24事噸のモノクローナル抗体を言んで2ジ その−刀ρ;ヒト絨毛狂 ゴナドトロピ/のα頭に柿汗し、1(!!力かヒト絨毛性ゴナドトロピンのβ瑣 にtri♂する請求の範囲4に記載の混きり013、α頚&C紹せする抗体がA lO2又、まAlO3と指部ざnβ鎖に結合する抗体がB102又はB103と 指杯びnる請求の4U!、d12にd己11vの75% 合II。 14、zz=団のモノクローナル抗体tざんで2す、双方がヒト紙毛丘ゴナドト ロピンのβ鎖にtj8し、夫々、BIOI及び131k)2と宿称さn6謂ボの 範囲4に記載の混合物。 ゛浄書(内容(こ変更なし) 15.固体マ) IJクスに吸着された請求の範囲1に記載の混合物を含む抗原 の高感度アッセイに有用な組成物。 16、適当に緩衝された溶液中に溶解した請求の範囲1に記載の混合物を含む抗 原の高感度アッセイに有用な組成物。 17、サンプル中の抗原の存在を測定するための方法であって、請求の範囲1に 記載の混合物とサンプルを、前記混合物と前記抗原との間で検出可能な複合体を 形成せしめ得る適当な条件下で、接触せしめることから成る方法。 18、サンプル中のヒト絨毛性ゴナドトロピンの存在を測定する方法であって、 サンプルと請求の範囲4,12.13又は14に記載の混合物とを、前記混合物 とヒト絨毛性ゴナドトロピンとの間に検出可能な複合体を形成せしめ得る条件下 で接触せしめることから成る方法。[Claims] 1. Antigen τ of the length of the instep A mixed proboscis of the null antibody, a different antigen site LC, and at least 2 proboscises of different antigens. :Kin's monoclonal antibody Riyatani τ/d young assay 81 formula: i? 9 appropriate Antigens and all monochrome ♂ things in the sweat strips. 2, 24iA Remonoclonal Enemy tzamugibo flood a Mouth kiss 3, cut, Nanamihara,) Bo1 no Pefuchito (: > 9 Ai+: flooded here +31i anti-)iHl list/Created Amino Toshikatsu C that has been added to the peptide Ru 61 Izuku no l Mi no 4 edition i 1-self machine's 7 konsunro. 4. Month 11. Self-horipeftid revenge ceremony, Nobuhito rR Takuo Ko' Natotorohishi (2 Rii = t4 PoL7Jfi-Regi: 'rr'J 1 v (iif; 4Qζ-62 ) 7m 61 course, v5, cut 60 polybegnato Aihara, 0 egg + g #lj is Hol Mo/de ruru 1; djiku no yoke, z6 1 vc5 self-+tv, 'D i B゛ ? /I 1b,j (jl (iself horipenotide 1JT, 7jjL,)i thyroid J lij 7 hormones de ril 1jrJ; F-'s corpse dlvc story I a, aIJ polypeptide 17LIJA2J The sign of the day, the first one is the fart of the people. 8. Square Og self-M efficacy assay weight is 616 self-antigens present in 4 in 1,000 self-sample samples. At least about 10% ρS is enough to form a fixed stand neo for each monochrome A mixture of cavities in 4QI51 of the award of null antibodies. 9. Violet of another antibody [friend of valley antibody against] - iα of about 10':l to about 1:106 1 Claim 1 contains a mixture containing 6 pins; Jl: 10" yoke d9 with 7 konzo proboscises. 11. The shield of the valley antibody against the firefly of another antibody is the ratio of the ridge size of the antibody to the antigen. The mixture J0 as stated in Claim 9 which is the same as the actual purchase 12, 24 stories of monoclonal antibodies and 2. persimmon sweat on the alpha head of gonadotropin, and 1 The antibody introduced in the mixture 013, α-neck & C according to claim 4 which is tri♂ lO2 or AlO3 and the antibody that binds to the finger chain β-chain are B102 or B103. 4U of finger cup binru bill! , 75% of d11v on d12. 14, zz = Group monoclonal antibody t, both of which are human paper hair gonadotes. tj8 in the β-chain of lopin, and the so-called n6 A mixture according to scope 4. ゛Engraving (contents (no changes)) 15. Solid matrix) Antigen containing the mixture according to claim 1 adsorbed on IJ matrix Compositions useful for sensitive assays. 16. Antibiotics containing the mixture according to claim 1 dissolved in a suitably buffered solution. Compositions useful for highly sensitive assays. 17. A method for determining the presence of an antigen in a sample, comprising: The mixture and sample described above are used to form a detectable complex between said mixture and said antigen. A method comprising contacting under suitable conditions to induce formation. 18. A method for determining the presence of human chorionic gonadotropin in a sample, the method comprising: The sample and the mixture according to claim 4, 12.13 or 14, and human chorionic gonadotropin under conditions capable of forming a detectable complex between A method consisting of bringing into contact with
JP50204483A 1982-05-21 1983-05-17 Monoclonal antibody mixture and use of said monoclonal antibody mixture for sensitive immunoassays Pending JPS59500986A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38095977653E 1982-05-21
PCT/US1983/000751 WO1983004312A1 (en) 1982-05-21 1983-05-17 Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays

Publications (1)

Publication Number Publication Date
JPS59500986A true JPS59500986A (en) 1984-05-31

Family

ID=22175145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50204483A Pending JPS59500986A (en) 1982-05-21 1983-05-17 Monoclonal antibody mixture and use of said monoclonal antibody mixture for sensitive immunoassays

Country Status (1)

Country Link
JP (1) JPS59500986A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6233200A (en) * 1985-08-07 1987-02-13 Chemo Sero Therapeut Res Inst Monoclonal antibody
JPS6238362A (en) * 1985-08-12 1987-02-19 Chemo Sero Therapeut Res Inst Method for measuring tsh

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6233200A (en) * 1985-08-07 1987-02-13 Chemo Sero Therapeut Res Inst Monoclonal antibody
JPS6238362A (en) * 1985-08-12 1987-02-19 Chemo Sero Therapeut Res Inst Method for measuring tsh

Similar Documents

Publication Publication Date Title
Tigelaar et al. Immunoglobulin receptors on mouse mast cells
Moore Chemistry and biology of two proteins, S-100 and 14-3-2, specific to the nervous system
Matthay et al. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004
Pernis et al. Immunoglobulin spots on the surface of rabbit lymphocytes
Eyer et al. Single-domain antibody fragments derived from heavy-chain antibodies: a review.
DE60224346T2 (en) Monoclonal antibody against the HCV core antigen
JP4851645B2 (en) Anti-procalcitonin antibodies, their preparation and use
Brandtzaeg Immunohistochemical studies on various aspects of glandular immunoglobulin transport in man
JPS59180362A (en) Use of anti-idiotype antibody in immune determination method
JPH07507210A (en) BNP antibody and immunoassay using it
CA2664327A1 (en) Method for detecting and treating skin disorders
JPH04503600A (en) Anti-interleukin-1α and -1β monoclonal antibodies, methods for producing the same, and application of the antibodies to detection and treatment of interleukin-1α and -1β
CN107022030A (en) Detect monoclonal antibody and kit and the application of alpha-fetoprotein
Pike et al. Immunochemical characterization of a monoclonal γG4, λ human antibody to factor IX
US20080248588A1 (en) Shrimp allergen, anti-shrimp allergen antibody, and use thereof
Vartdal et al. Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies.
US5780298A (en) DNA encoding the sn-RNP-A antigen and fragments thereof
King et al. Melittin-specific monoclonal and polyclonal IgE and IgG1 antibodies from mice.
FI95579C (en) Method for selective immunologic determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and agents for carrying out this
Young et al. Studies in serum proteins: Agammaglobulinemia in the adult
JPS59500986A (en) Monoclonal antibody mixture and use of said monoclonal antibody mixture for sensitive immunoassays
Kriebel Jr et al. Locally produced antibody in human gastrointestinal secretions
Devendra et al. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes
CN110183530A (en) Leptin immunogene, hybridoma, monoclonal antibody, polyclonal antibody and application
Rejnek et al. Electrophoretic behaviour of H and L chains of human serum and colostrum gamma-globulin